These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


545 related items for PubMed ID: 9072782

  • 1. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J, Esquivel Ayanegui F, Esquivel Rodríguez F, Sáenz V, Santoyo R.
    Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
    [Abstract] [Full Text] [Related]

  • 2. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 3. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 4. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A, Dattilo M.
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [Abstract] [Full Text] [Related]

  • 5. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 26; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S, Sato A, Sakurada H, Takeda T, Hongo M, Toyota T.
    J Clin Gastroenterol; 1995 Nov 26; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [Abstract] [Full Text] [Related]

  • 8. [Effect of the observance of diurnal fast of Ramadan on duodenal ulcer healing with lansoprazole. Results of a prospective controlled study].
    Mehdi A, Ajmi S.
    Gastroenterol Clin Biol; 1997 Nov 26; 21(11):820-2. PubMed ID: 9587532
    [Abstract] [Full Text] [Related]

  • 9. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N.
    Nihon Rinsho; 1992 Jan 26; 50(1):68-73. PubMed ID: 1347332
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP, Slama JL, Licht H, Lemerez M, Coste T, Andrieu J, Grimaud JC, Julien H, Dupuis J, Sallerin V.
    Gastroenterol Clin Biol; 1993 Jan 26; 17(5):334-40. PubMed ID: 8349067
    [Abstract] [Full Text] [Related]

  • 11. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
    Avner DL, Movva R, Nelson KJ, McFarland M, Berry W, Erfling W.
    Am J Gastroenterol; 1995 Aug 26; 90(8):1289-94. PubMed ID: 7639232
    [Abstract] [Full Text] [Related]

  • 12. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr 26; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar 26; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 14. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E.
    Leber Magen Darm; 1994 Mar 26; 24(2):66-8, 71. PubMed ID: 8196467
    [Abstract] [Full Text] [Related]

  • 15. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A, Ahuja V, Bal CS, Das B, Pandey RM, Sharma MP.
    Helicobacter; 2004 Apr 26; 9(2):124-9. PubMed ID: 15068413
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.
    Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910
    [Abstract] [Full Text] [Related]

  • 17. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M, Bargiggia S, Bianchi Porro G.
    Am J Gastroenterol; 1997 Apr 01; 92(4):649-52. PubMed ID: 9128316
    [Abstract] [Full Text] [Related]

  • 18. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 01; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 19. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Mar 01; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 20. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
    Chu KM, Kwok KF, Law SY, Wong J.
    Hepatogastroenterology; 2000 Mar 01; 47(36):1624-6. PubMed ID: 11149018
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.